Lexaria Bioscience Corp.
LEXX
$1.35
-$0.34-20.12%
NASDAQ
| 02/28/2025 | 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | |
|---|---|---|---|---|---|
| Net Income | -0.35% | -23.75% | -22.62% | -174.32% | 44.92% |
| Total Depreciation and Amortization | -77.00% | 61.29% | 13.76% | -3.11% | -43.32% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 43.86% | 21.97% | -77.44% | 5,252.56% | -92.32% |
| Change in Net Operating Assets | 687.36% | -201.78% | 128.18% | 19,175.00% | 99.72% |
| Cash from Operations | 45.05% | -44.10% | -49.41% | -104.34% | 47.57% |
| Capital Expenditure | 100.00% | 42.79% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -111.36% | 50.38% | -20.91% | 61.40% | -42.50% |
| Cash from Investing | 26.19% | 45.69% | -216.36% | 61.40% | -42.50% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.73% | -- | -100.00% | 46.06% | 89.78% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -99.73% | -- | -100.00% | 46.06% | 89.78% |
| Foreign Exchange rate Adjustments | -2,878.13% | -252.38% | 275.00% | 95.20% | -668.18% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -201.96% | 180.56% | -152.19% | 36.44% | 356.93% |